This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Church & Dwight's (CHD) International Unit to Aid Q4 Earnings
by Zacks Equity Research
Church & Dwight's (CHD) organic sales gain from strong international business, which is likely to boost Q4 results.
Factors to Know Ahead of Estee Lauder's (EL) Q2 Earnings
by Zacks Equity Research
Estee Lauder (EL) gains from buyouts, travel retail network and strong online sales. However, a tough macroeconomic landscape, stiff competition and changing consumer preferences poses concern.
Can Clorox (CLX) Retain Earnings Beat Trend Despite All Odds?
by Zacks Equity Research
Clorox's (CLX) second-quarter fiscal 2019 results are poised to benefit from the ongoing 2020 Strategy, e-commerce enhancement and brand investments. However, margin woes may hurt results.
Colgate (CL) Q4 Earnings Beat, Soft 2019 View Hurts Stock
by Zacks Equity Research
Colgate's (CL) fourth-quarter 2018 earnings and sales beat estimates on solid organic sales, and improved pricing. However, the company issues a soft earnings view for 2019.
Factors to Watch Ahead of Blue Apron's (APRN) Q4 Earnings
by Zacks Equity Research
Blue Apron Holdings (APRN) is on track with key strategic priorities like strengthening portfolio, improving customer experience and solidifying distribution channels.
McCormick's (MKC) Q4 Earnings Lag Estimates, Sales Up Y/Y
by Zacks Equity Research
McCormick's (MKC) Q4 performance gains from new product offerings and strength in the base business. However, unfavorable product mix and currency impacts weigh on results.
Procter & Gamble (PG) Rises on Q2 Earnings Beat, Ups View
by Zacks Equity Research
Organic sales growth across most segments aids Procter & Gamble's (PG) earnings and sales in second-quarter fiscal 2019. The company raises organic sales view for fiscal 2019.
Estee Lauder Gains from Sales Channels, Tariff Woes Persist
by Zacks Equity Research
Estee Lauder (EL) gains from steady growth in online and travel retail sales channels. However, tariff impacts in China and weak U.K. beauty market are concerns.
Can Nu Skin's Sales Leaders & Customers Revive Lost Sheen?
by Zacks Equity Research
Nu Skin (NUS) grapples with sluggish gross margin and adverse currency trends. Nevertheless, strength in sales leaders and customers are encouraging.
Will Church & Dwight (CHD) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Church & Dwight (CHD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 Soaps and Cleaning Materials Stocks Set to Beat Q4 Earnings
by Zacks Equity Research
The Soaps and Cleaning Materials industry remains lucrative, backed by product innovation, and cost-saving and restructuring efforts despite soft sales and margins woes.
Will Colgate (CL) Retain Earnings Trend in Q4 Despite Odds?
by Zacks Equity Research
Colgate (CL) witnesses soft top line and strained margins, owing to tough operating environment and higher costs. However, its beat or meet earnings trend is likely to continue in fourth-quarter 2018.
Restructuring to Drive Kimberly-Clark's (KMB) Q4 Earnings
by Zacks Equity Research
Kimberly-Clark's (KMB) focus on key growth initiatives ??? FORCE and Global Restructuring Programs ??? bode well for Q4. Competition in the diaper category and escalated costs are concerning.
Sysco Down 10% in 3 Months: International Unit & Costs Hurt
by Zacks Equity Research
Sysco (SYY) is bearing the brunt of high costs stemming from a tight labor market and higher supply-chain expenses.
Colgate Stock Loses Ground: Can Strategies Aid a Turnaround?
by Zacks Equity Research
Colgate's (CL) grapples with soft sales and strained margins for quite a while now. Nevertheless, the company's cost-savings program appears promising.
The Zacks Analyst Blog Highlights: McCormick, Procter & Gamble, Church & Dwight, Ollie's Bargain Outlet and Lamb Weston
by Zacks Equity Research
The Zacks Analyst Blog Highlights: McCormick, Procter & Gamble, Church & Dwight, Ollie's Bargain Outlet and Lamb Weston
5 Consumer Staples Stocks That Escaped 2018 Sector Shortfall
by Vrishali Bagree
Despite the barriers in the consumer staples sector, there are some companies that look promising on the back of solid pricing initiatives, focus on innovation and diversification.
Clorox's (CLX) 2020 Strategy on Track, Margin Woes Linger
by Zacks Equity Research
Clorox (CLX) benefits from 2020 strategy, expansion of e-commerce capabilities and brand management initiatives. However, dismal margins and soft fiscal earnings view are concerns.
Will Church & Dwight (CHD) Sustain its Robust Record in 2019?
by Zacks Equity Research
Church & Dwight (CHD) has been riding on strength in its Consumer International segment, benefits from acquisitions and impressive organic sales trend.
Here's Why You Should Hold on to Keurig Dr Pepper Stock Now
by Zacks Equity Research
Keurig Dr Pepper's (KDP) strong performance in third-quarter 2018 and a promising outlook, alongside its partnerships and acquisition strategy, position it for growth in the future.
Avon (AVP) Eyes Korean Beauty Space, Transformation on Track
by Zacks Equity Research
Avon (AVP) partners with K-beauty, stepping into the lucrative Korean beauty market as part of its business transformation efforts.
P&G (PG) Buys Walker & Company, Enhances Beauty Portfolio
by Zacks Equity Research
P&G (PG) acquires health and beauty solutions company Walker & Company Brands. The buyout should bolster P&G's multicultural business and speed up growth of Walker & Company's existing brands.
Colgate (CL) Stock Down 14.3% YTD: What You Should Know
by Zacks Equity Research
Colgate's (CL) dismal performance can be attributed to uncertain global markets. Also, a dismal sales trend is worrisome. However, the company's savings programs appear impressive.
Bear of the Day: Colgate-Palmolive (CL)
by Madeleine Johnson
Earnings estimated have fallen sharply for this consumer staples giant.
P&G (PG) Acquires Merck KGaA's Consumer Health Business
by Zacks Equity Research
P&G (PG) closes the acquisition of Merck KGaA's consumer-health business. This should bolster the company's OTC geographic scale, brand portfolio and category footprint.